INCRESCENDO 1(1) 2010 - Revista Peruana
INCRESCENDO 1(1) 2010 - Revista Peruana
INCRESCENDO 1(1) 2010 - Revista Peruana
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3. Soto V, Zavaleta S, Bernilla J. Factores determinantes del abandono del Programa de Hipertensión<br />
Arterial. Hospital Nacional “Almanzor Aguinaga Asenjo” EsSalud, Chiclayo 2000. Anales<br />
de la Facultad de Medicina Universidad Nacional Mayor de San Marcos. ISSN 1025 – 5583. Vol.<br />
63, Nº 3 - 2002. Págs. 185 – 190.<br />
4. Dualde VE. Control y seguimiento de medicación en pacientes hipertensos. Pharm Care Esp<br />
1999; 1: 28-34.<br />
5. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. The Seventh Report of the Joint National<br />
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH<br />
Publication No. 03 - 5233.<br />
6. Agusti CR. Epidemiología de la hipertensión arterial en el Perú. Acta Med Per. 23(2) 2006 69.<br />
7. Sosa JM. Talledo R. Portugal RM. Jefferson L. ESTILOS DE VIDA Y PREVALENCIA DE HIPERTEN-<br />
SIÓN ARTERIAL EN TRES COMUNIDADES PERUANAS. <strong>Revista</strong> <strong>Peruana</strong> de Cardiología : Mayo -<br />
Agosto 1999.<br />
8. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. The effect of clinical pharmacy<br />
services on patients with essential hypertension. Circulation. 1973;48:1104-11.<br />
9. Morse GD, Douglas JB, Upton JH, Rodgers S, Gal P. ffect of pharmacist intervention on control<br />
of resistant hypertension. Am J Hosp Pharm. 1986 Apr;43(4):905-9.<br />
10. World Health Organization. Europe: Pharmacy-Based Hypertension Management Model: Protocol<br />
and Guidelines. A joint CINDI/EuroPharm Forum project 2005. EUR/04/5049481. ISBN<br />
WHOLIS: E85730.<br />
11. Foppe van Mil J. W. Schulz M. A Review of Pharmaceutical Care in Community Pharmacy in<br />
Europe. Harvard Health Policy Review. Vol. 7. No 01. spring 2006. Desde:<br />
http://www.hcs.harvard.edu/~hhpr/publications/previous/06s/van_Mil_and_Schulz.pdf.<br />
12. Bernal IF. López JJ., Gerena BE. Diseño e implementación de una estrategia para el mejoramiento<br />
del cumplimiento farmacoterapéutico en el paciente hipertenso. <strong>Revista</strong> Colombiana de<br />
Ciencias Químico Farmacéuticas. Vol. 30. Diciembre de 2001.<br />
13. Blenkinsopp A, Phelan M, Bourne J, Dakhil N. Extended adherence support by community pharmacists<br />
for patients with hypertension: a randomised controlled trial. Int J Pharm Pract<br />
2000:8:165-75<br />
14. Mehos BM. Saseen JJ. MacLaughlin EJ. Effect of Pharmacist Intervention and Initiation of Home<br />
Blood Pressure Monitoring in Patients with Uncontrolled Hypertension. Pharmacotherapy<br />
20(11):1384-1389, 2000. © 2000 Pharmacotherapy Publications. En: http://<br />
www.medscape.com/viewarticle/409647<br />
15. Taylor Ch T, Byrd DC. Krueger K. Improving primary care in rural alabama with a pharmacy initiative.<br />
Am j health-syst pharm-vol 60 jun 1, 2003.<br />
16. Lai LL. Community pharmacy-based hypertension disease-management program in a<br />
Latino/Hispanic-American population. Consult Pharm. 2007 May;22(5):411-6.<br />
17. Chabot I. Moisan J. Grégoire JP. Milot A. Pharmacist Intervention Program for Control of<br />
Hypertension. Ann Pharmacother. 2003; 37: 1186-1193 publicado en línea: July 10, 2003.<br />
www.theannals.com, DOI 10.1345/aph.1C267.<br />
18. Garção JA, Cabrita J. Evaluation of a Pharmaceutical Care Program for Hypertensive Patients in<br />
Rural Portugal. J Am Pharm Assoc 42(6):858-864, 2002. © 2002 American Pharmaceutical Association.<br />
Posted 03/28/2003.<br />
19. Hepler CD. Strand LM. Oportunidades y responsabilidades en la Atención Farmacéutica. Pharm<br />
Care Esp 1999; 1:35-47.<br />
20. Grupo de Investigación en Atención Farmacéutica, Universidad de Granada. Seguimiento farmacoterapéutico:<br />
Método Dáder (3ª revisión: 2005). Pharmacy Practice 2006; 4(1): 44-53.<br />
112 /<br />
Percy Alberto Ocampo Rujel<br />
IN CRESCENDO 1(1) <strong>2010</strong>